Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice

Vaccine

Volumn 17, Issue 22, 1999, Pages 2836-2843

  Bharadwaj, Mausumi ^a   Lyons, C Richard ^a   Wortman, Ivo A ^a   Hjelle, Brian ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

DNA vaccine; Genetic immunization; Lymphoproliferative response; Neutralizing antibodies; Sin Nombre hantavirus immune response

Indexed keywords

COMPLEMENTARY DNA; NUCLEOTIDE; VIRUS DNA; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; HANTAVIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS GENE;

EID: 0033575481     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00096-1     Document Type: Article

References (33)

1. Mertz GJ, Hjelle BL, Bryan RT. Hantavirus infection. In: Fauci AS, Schrier RW, editors. Advances in Internal Medicine, Mosby Year Book. Mosby, Chicago, 1997:373-425.
2. Schmaljohn C., Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis. 3:1997;95-104.
3. Brummer-Korvenkontio M., Vaheri A., von Bonsdorff C.H., Vuorimies J., Manni T., Penttinen K., Oker-Blom N., Lahdevirta J. Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis. 141:1980;131-134.
4. Childs J.E., Ksiazek T.G., Spiropoulou C.F., Krebs J.W., Morzunov S., Maupin G.O., Gage K.L., Rollin P., Sarisky J., Enscore R., Peters C.J., Nichol S.T. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis. 169:1994;1271-1280.
5. Lee H., van der Groen G. Hemorrhagic fever with renal syndrome. Prog Med Virol. 36:1989;62-102.
6. Lee H., Lee P., Johnson K. Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis. 137:1978;298-308.
7. Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome. Morb Mortal Wkly Rep 1998;47:449-452.
8. Nichol S.T., Spiropoulou C.F., Morzunov S., Rollin P.E., Ksiazek T.G., Feldmann H., Sanchez A., Childs J.E., Zaki S., Peters C.J. Genetic identification of a novel hantavirus associated with an outbreak of acute respiratory illness in the southwestern United States. Science. 262:1993;914-917.
9. Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome-Chile. Morb Mortal Wkly Rep 1997;46:949-951.
10. López N., Padula P., Rossi C., Lazaro M.E., Franze-Fernandez M.T. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology. 220:1996;223-226.
11. Hantavirus Pulmonary Syndrome Study Group for Patagonia, Wells R.M., Estani S.S., Yadon Z.E., Enria D., Padula P., Pini N., Mills J.N., Peters C.J., Segura E.L. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg Infect Dis. 3:1997;171-174.
12. Williams R.J., Bryan R.T., Mills J.N., Palma R.E., Vera I., De Velasquez F., Baez E., Schmidt W.E., Figueroa R.E., Peters C.J., Zaki S.R., Khan A.S., Ksiazek T.G. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg. 57:1997;274-282.
13. Schmaljohn C.S. Molecular biology of hantaviruses. Elliott R.M. The Bunyaviridae. 1996;63-90 Plenum, New York.
14. Chu Y.-K., Jennings G.B., Schmaljohn C.S. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul virus but not Puumala virus. J Virol. 69:1995;6417-6423.
15. Lundkvist Å., Kallio-Kokko H., Sjolander K.B., Lankinen H., Niklasson B., Vaheri A., Vapalahti O. Characterization of Puumala virus nucleocapsid protein: identification of B cell epitopes and domains involved in protective immunity. Virology. 216:1996;397-406.
16. Whalen R.G. DNA vaccines for emerging infectious diseases: what if? Emerg Infect Dis. 2:1996;168-175.
17. Hjelle B., Spiropoulou C.F., Torrez-Martinez N., Morzunov S., Peters C.J., Nicole S.T. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J Infect Dis. 170:1994;1013-1017.
18. Hjelle B., Jenison S., Torrez-Martinez N., Yamada T., Nolte K., Zumwalt R., MacInnes K., Myers G. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J Virol. 68:1994;592-596.
19. Jenison S., Yamada T., Morris C., Anderson B., Torrez-Martinez N., Keller N., Hjelle B. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol. 68:1994;3000-3006.
20. Harrington M.G. Elution of protein from gels. Methods Enzymol. 182:1990;488-495.
21. Bharadwaj M., Botten J., Torrez-Martinez N., Hjelle B. Rio Mamore virus: genetic characterization of a newly recognized hantavirus of the pygmy rice rat, Oligoryzomys microtis from Bolivia. Am J Trop Med Hyg. 57:1997;368-374.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature. 227:1970;680-685.
23. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
24. Mishell BB, Shiigi SM, Chan EL, et. al. Preparation of mouse cell suspensions. In: Mishell BB and Shiigi ST, (eds), Selected methods in cellular immunology, W.H Freeman and company, New York, 1979: 3-27.
25. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 158:1997;816-826.
26. Niklasson B., Jonsson M., Lundkvist A., Horling J., Tkachenko E. Comparison of European isolates of viruses causing hemorrhagic fever with renal syndrome by a neutralization test. Am J Trop Med Hyg. 45:1991;660-665.
27. Lundkvist A., Niklasson B. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization. Arch Virol. 126:1992;93-105.
28. Canon M.J. Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice. J Virol Methods. 16:1987;293-301.
29. Ulmer J.B., Donnelly J.J., Parker S.E., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
30. Choi A.H.C., Basu M., Rae M.N., McNeal M.M., Ward R.L. Particle-bombardment mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology. 250:1998;230-240.
31. Gerdts V., Jons A., Makoschey B., et al. Protection of pigs against Aujeszky's disease by DNA vaccine. J Gen Virol. 78:(Pt 9):1997;2139-2146.
32. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 272:1996;104-107.
33. Davis H.L., Michel M.L., Whalen R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet. 2:1993;1847-1851.